Skip to main content
Investor Relations Contact Us Careers
Nasdaq: FEMY
News Item

Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter

May 13, 2026

Femasys received CE Mark approval for its FemHSG Catheter, expanding the company’s fertility diagnostics portfolio into the European market.

View source →
← Back to Media